Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-11-21

Clinical Trial Update: Platelet Rich Plasma Injection vs Percutaneous Tenotomy for Common Extensor Tendinopathy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Platelet Rich Plasma injection to percutaneous tenotomy for lateral epicondylitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Percutaneous tenotomy
  • Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Lateral Epicondylitis (Tennis Elbow) | Phase 4 | Status: WITHDRAWN